Ergtoxin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 20: | Line 20: | ||
{{biochemistry-stub}} | {{biochemistry-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 11:03, 17 March 2025
Ergtoxin is a peptide that is derived from the venom of the scorpion species Centruroides noxius. It is a potassium channel blocker, which means it inhibits the flow of potassium ions through the channel, affecting the electrical conductivity of the cells.
Structure[edit]
Ergtoxin is a 37-amino acid peptide with a molecular weight of approximately 4 kDa. It has a compact, stable structure that is maintained by three disulfide bonds. The structure of ergtoxin is similar to other scorpion venom peptides, with a core of beta-sheets surrounded by alpha-helixes.
Function[edit]
Ergtoxin acts as a potent inhibitor of voltage-gated potassium channels, specifically the Kv1.3 channel. This channel is found in the membrane of many cells, including neurons and T cells. By blocking this channel, ergtoxin disrupts the normal flow of potassium ions, which can affect the electrical activity of the cell. This can lead to a variety of effects, including neurotoxicity and immunosuppression.
Medical Applications[edit]
Due to its ability to block Kv1.3 channels, ergtoxin has potential applications in the treatment of diseases such as autoimmune diseases, cancer, and neurological disorders. However, further research is needed to fully understand the potential benefits and risks of using ergtoxin in medical treatments.
See Also[edit]

This article is a biochemistry stub. You can help WikiMD by expanding it!
